Viking Therapeutics Inc. (VKTX)
NASDAQ: VKTX
· Real-Time Price · USD
40.04
-0.20 (-0.50%)
At close: Aug 15, 2025, 3:59 PM
40.74
1.75%
After-hours: Aug 15, 2025, 07:57 PM EDT
Viking Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 33.88M | 37.94M | 26.68M | 50.35M | 43.91M | 195.58M | 55.52M | 37.19M | 69.52M | 18.36M | 36.63M | 29.41M | 16.23M | 12.45M | 26.37M | 11.26M | 8.83M | 16.8M |
Short-Term Investments | n/a | 813.92M | 875.94M | 880.09M | 898.35M | 767.4M | 306.56M | 339.06M | 323.4M | 117.3M | 118.85M | 125.61M | 152.69M | 172.44M | 175.73M | 204.87M | 219.43M | 224.87M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 54K | 78K | 102K | 126K | 138K | 131K | 139K | 163K | 49K | 81K | 71K | 48K | 85K | 97K | 109K | 88K | 7K | 27K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 793.14M | 865K | 1.13M | 1.73M | 3.32M | 2.72M | 2.52M | 670K | 960K | 3.93M | 3.41M | n/a | n/a | n/a | 7.81M | n/a | n/a | n/a |
Total Current Assets | 827.02M | 866.02M | 907.22M | 936.65M | 945.72M | 966.34M | 367.23M | 381.3M | 399.37M | 149.47M | 167.04M | 165.15M | 179.86M | 193.3M | 210.53M | 224.28M | 237.66M | 249.86M |
Property-Plant & Equipment | 780K | 892K | 1M | 1.11M | 977K | 1.05M | 1.13M | 1.2M | 1.27M | 1.35M | 1.42M | 1.49M | 1.56M | 1.63M | 25K | 101K | 176K | 249K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 834K | 970K | 1.1M | 1.24M | 1.11M | 1.18M | 1.26M | 1.36M | 1.32M | 1.43M | 1.49M | 1.54M | 1.65M | 1.73M | 134K | 189K | 183K | 276K |
Total Assets | 827.85M | 866.99M | 908.32M | 937.89M | 946.84M | 967.52M | 368.49M | 382.66M | 400.69M | 150.9M | 168.53M | 166.68M | 181.51M | 195.03M | 210.66M | 224.47M | 237.84M | 250.14M |
Account Payables | 5.49M | 7.7M | 9.81M | 254K | 11.09M | 5.22M | 7.51M | 5.71M | 5.61M | 3.8M | 8.53M | 3.14M | 6.1M | 3.12M | 1.44M | 2.85M | 4.21M | 4.85M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -238K | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 468K | n/a | n/a | 480K | 334K | n/a | 324K | 319K | 314K | n/a | 304K | 299K | 238K | 150K | 29K | 115K | 198K | 279K |
Other Current Liabilities | 26.02M | 11.37M | n/a | 24.95M | -334K | n/a | -324K | -319K | -314K | n/a | -304K | -299K | -238K | -150K | -29K | -115K | -198K | -279K |
Total Current Liabilities | 31.98M | 19.57M | 27.41M | 25.68M | 25.09M | 32.77M | 19.14M | 13.4M | 13.48M | 15.65M | 21.95M | 14.06M | 14.86M | 11.27M | 8.78M | 11.35M | 12.87M | 12.92M |
Long-Term Debt | 410K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 410K | 502K | 630K | 755K | 766K | 852K | 936K | 1.02M | 1.1M | 1.18M | 1.26M | 1.34M | 1.41M | 1.49M | 1.47M | 2.97M | 4.41M | 5.13M |
Total Liabilities | 32.39M | 20.07M | 28.04M | 26.44M | 25.86M | 33.63M | 20.07M | 14.42M | 14.58M | 16.83M | 23.21M | 15.4M | 16.28M | 12.76M | 8.78M | 11.35M | 12.87M | 12.92M |
Total Debt | 878K | 1M | 1.12M | 1.24M | 1.1M | 1.18M | 1.26M | 1.34M | 1.41M | 1.49M | 1.56M | 1.64M | 1.65M | 1.64M | 29K | 115K | 198K | 279K |
Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K |
Retained Earnings | -599.1M | -533.54M | -487.91M | -452.49M | -427.55M | -405.3M | -377.94M | -353.34M | -330.81M | -311.58M | -292.05M | -272.49M | -256.72M | -239.28M | -223.18M | -210.83M | -197.58M | -182.2M |
Comprehensive Income | -166K | -216K | -788K | 1.63M | -2.27M | -1.6M | -389K | -905K | -1.04M | -618K | -1.1M | -1.76M | -1.65M | -1.41M | -549K | -170K | -189K | -104K |
Shareholders Equity | 795.46M | 846.92M | 880.28M | 911.45M | 920.98M | 933.89M | 348.42M | 368.24M | 386.12M | 134.06M | 145.32M | 151.28M | 165.23M | 182.27M | 201.88M | 213.12M | 224.97M | 237.22M |
Total Investments | n/a | 813.92M | 875.94M | 880.09M | 898.35M | 767.4M | 306.56M | 339.06M | 323.4M | 117.3M | 118.85M | 125.61M | 152.69M | 172.44M | 175.73M | 204.87M | 219.43M | 224.87M |